BioGeneration Ventures (BGV) is a venture capital firm specializing in seed investments in innovative early-stage European life sciences companies. BGV typically acts as the lead investor, focusing on biotech companies developing disruptive solutions for high unmet medical needs. BGV is the early-stage strategy of the Forbion-BGV platform of funds, which also includes Forbion Ventures and Forbion Growth. The firm supports biotech companies throughout all stages of development, from company formation (Build, Seed, Series A) through company building (Build, Enable, Series A-B) and company expansion (Crossovers, VIPE/PIPE, Series B/C). They look for opportunities to translate rough scientific ideas into therapeutic products, emphasizing patient impact and attracting additional investment.
Bevorzugte Reifephase für die erste Finanzierung.
Biotech, Life Sciences, Pharmaceuticals, Therapeutics, Oncology, Immunology, Nephrology, Chronic Diseases, Cell Therapy, Synthetic Lethality in Cancer
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...